BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31128428)

  • 1. Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims database.
    Esposito DB; Russo L; Oksen D; Yin R; Desai VCA; Lyons JG; Verpillat P; Peñalvo JL; Lamy FX; Lanes S
    Cancer Epidemiol; 2019 Aug; 61():30-37. PubMed ID: 31128428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data.
    Beachler DC; de Luise C; Yin R; Gangemi K; Cochetti PT; Lanes S
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):171-178. PubMed ID: 30411431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.
    Lyons J; Desai V; Xu Y; Ridgeway G; Finkle W; Solari P; Sullivan S; Lanes S
    Value Health; 2018 Sep; 21(9):1098-1103. PubMed ID: 30224115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer.
    Beachler DC; Lamy FX; Russo L; Taylor DH; Dinh J; Yin R; Jamal-Allial A; Dychter S; Lanes S; Verpillat P
    J Ovarian Res; 2020 Aug; 13(1):101. PubMed ID: 32867806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with advanced-stage Merkel cell carcinoma at initial diagnosis and the use of radiation therapy: Results from the National Cancer Database.
    Trofymenko O; Zeitouni NC; Kurtzman DJB
    J Am Acad Dermatol; 2018 Oct; 79(4):680-688. PubMed ID: 29574087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States.
    Kearney M; Thokagevistk K; Boutmy E; Bharmal M
    J Med Econ; 2018 Dec; 21(12):1159-1171. PubMed ID: 30149739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.
    Ward EM; Fedewa SA; Cokkinides V; Virgo K
    Cancer J; 2010; 16(6):614-21. PubMed ID: 21131794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data.
    Beachler DC; Taylor DH; Anthony MS; Yin R; Li L; Saltus CW; Li L; Shaunik A; Walsh KE; Rothman KJ; Johannes CB; Aroda VR; Carr W; Goldberg P; Accardi A; O'Shura JS; Sharma K; Juhaeri J; Lanes S; Wu C
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):918-926. PubMed ID: 33899314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
    Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a Case-Finding Algorithm for Identifying Patients with Non-small Cell Lung Cancer (NSCLC) in Administrative Claims Databases.
    Turner RM; Chen YW; Fernandes AW
    Front Pharmacol; 2017; 8():883. PubMed ID: 29249970
    [No Abstract]   [Full Text] [Related]  

  • 12. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
    Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
    Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Socioeconomic Status on Stage at Presentation of Laryngeal Cancer in the United States.
    Lebo NL; Khalil D; Balram A; Holland M; Corsten M; Ted McDonald J; Johnson-Obaseki S
    Otolaryngol Head Neck Surg; 2019 Nov; 161(5):800-806. PubMed ID: 31184265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
    Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
    J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
    Koshy M; Malik R; Mahmood U; Husain Z; Weichselbaum RR; Sher DJ
    J Natl Cancer Inst; 2015 Dec; 107(12):djv278. PubMed ID: 26424779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
    Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
    Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
    Ansaripour A; Zendehdel K; Tadayon N; Sadeghi F; Uyl-de Groot CA; Redekop WK
    PLoS One; 2018; 13(10):e0205079. PubMed ID: 30273393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.